In addition, the AST/ALT ratio is included in the FIB-4 score, which is used for the noninvasive diagnosis of liver fibrosis (20); however, the effect of an elevated AST/ALT ratio on the risk of mortality or liver transplantation is unknown. This evidence concerns the gene GPT and Hepatic fibrosis.